Key Roles & Honors

• Founder & General President. Fuda Cancer Hospital, Jinan University.
• Chief Expert, National Clinical Key Specialty (Oncology).
• Lifetime Honorary President, International Society for Cryosurgery; Founder, Asian Society for Cryosurgery.

Awards

• “Bethune Medal” (China’s highest medical honor, 2012).
• “Model of the Times” (2014); WHO-recognized “Distinguished Contributor to World Cryosurgery Technology” (2015).
• Gold Award, Japanese Society for Low Temperature Medicine.

Career Highlights

• Clinical & Academic Leadership
• Early Research: Innovated GGT1 for liver cancer diagnosis (National Science and Technology Progress Award).
• Monographs: Authored China’s first texts on *Digestive Diseases*, *Pancreatic Diseases*, *Tumor Cryosurgery*, and *Modern Cryosurgery for Cancer* (500+ papers,
  100+ SCI).
• Global Influence: Lectured at WHO (Geneva, 2015) and universities worldwide (Japan,
  U.S., Europe).

Innovative Therapies

1. Cryosurgery : Advanced tumor ablation techniques, establishing China as a leader in the field.
2. Cancer Composite Immunotherapy (CCI) : Developed with Academician Wang Zhenyi, treating thousands of advanced cancer patients.
3. Hydrogen Medicine :
– Introduced “Hydrogen Control of Cancer (HCC)” concept, publishing *Hydrogen Control of Cancer: Theory and Practice.
– First President, International Society for Clinical Hydrogen Medicine.

Philosophical Contributions

• Proposed “Coexisting with Cancer” and “ Combining Elimination and Transformation”(with Academician Tang Zhaoyou), emphasizing long-term patient survival and
  quality of life.

Global Impact

• Treated patients from 110+ countries, including Southeast Asia, Middle East, Europe, and North America.
• Bridged traditional Chinese medical philosophy with modern oncology, redefining cancer care paradigms. Legacy : A visionary integrating clinical innovation, research, and
  compassionate care to transform global oncology practice.